Letters Guidance on collaboration with drug industry

Towards greater transparency in the life sciences

BMJ 2012; 344 doi: https://doi.org/10.1136/bmj.e3371 (Published 15 May 2012) Cite this as: BMJ 2012;344:e3371
  1. Richard Thompson, president1,
  2. Deepak Khanna, president2
  1. 1Royal College of Physicians, London NW1 4LE, UK
  2. 2Association of British Pharmaceutical Industry, London, UK
  1. the.president{at}rcplondon.ac.uk

After the recent publication of guidance on collaboration between healthcare professionals and the drug industry,1 the BMJ printed two letters of criticism to which we would like to respond.2 3 This guidance is just the first step in a series of work by the Ethical Standards in Health and Life Sciences Group (ESHLSG) to tackle problems in the relationship between …

View Full Text

Log in

Log in through your institution


* For online subscription